POSSIBILITY OF COVID-19 RE-INFECTION & LOSS OF ANTIBODIES
Coronavirus is attracting the attention of healthcare professionals and scientists searching for its treatment and vaccine. The study of antibodies is crucial in the development of medicine and the immunization of coronavirus. Antibodies are molecules that are produced by the body or immune system to fight infection. The purpose of this research paper was to determine antibody loss and Covid-19 reinfection.
Antibodies are crucial even if they are produced in small quantities because they can still neutralize the virus. Various researchers show that patients are losing their IgG antibodies. Studies found that about 10% of almost 1,500 patients recovered from Covid-19 produced antibodies out of which 74 lost their antibodies two to three months after recovery.
Studies have revealed that the antibodies level is high during the first three weeks of infection and then declines. Patients with severe illness have more antibody levels than those with mild or asymptomatic patients. It is possible for patients who have recovered from Covid-19 to get infected again; however, researchers should conduct more studies to prove this argument.
The methodology used in this study was the literature search. The researcher obtained data from various literature work and data obtained analyzed qualitatively by identifying and deriving meaning from the literature work. The findings suggest that patients who have recovered from coronavirus are losing their antibodies. The study also found that Covid-19 recovered patients can be affected again, but more research is needed.
The discussion section of the paper discussed the findings by relating them with what other researchers have found. One limitation of the study was the few scientific journals and peer-reviewed articles to support the conclusions. The future scope is the need for further research.
Zhu, N., Zhang, D., Wang, W., and Li, X.
A novel coronavirus from patients with pneumonia in China
The New England Journal of Medicine (2020)
National Health Institute
Potent antibodies found in people recovered from COVID-19
National Institute of Health Research Matters (30 June 2020)
Vabret, N., Britton,G.J., Gruber, C., Hedge, S., et al.
Immunology of COVID-19: Current State of the Science
Elsevier Public Health Emergency Collection (vol. 52, no. 6, pp. 910-941, 16 June 2020)
World Health Organization
Immunity passports" in the context of COVID-19
Scientific Brief, (24 April 2020)
Robbiani, D.F., Gaebler, C., & Nussenzweig, M.C.
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
Nature, (18 June 2020)
Qin C., Zhou L., Hu Z., Zhang S., Yang S., Tao Y., Xie C., Ma K., Shang K., Wang W., Tian D.-S.
Dysregulation of immune response in patients with COVID-19 in Wuhan, China
Clin. Infect. Dis, (2020)
Malgaco,J.G., Azamor, T., & Bom, A.P.D.A
Protective immunity after COVID-19 has been questioned: What can we do without SARS-CoV-2-IgG detection?
Cell Immunology, (2020)
Wu F., Wang A., Liu M., Wang Q., Chen J., Xia S., Ling Y., Zhang Y., Xun J., Lu L., Jiang S., Lu H., Wen Y., & Huang, J.
Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications
Infectious Diseases, (2020)
Callaway, E., Ledford, H., & Mallapaty, S.
Six months of coronavirus: the mysteries scientists are still racing to solve
Nature Research Journal, (03 July 2020)
Centers for Disease Control and Prevention
Coronavirus disease 2019: Test forpast infection
(30 June 2020)
Zhang W, Du R, Li B, & Zheng X
Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes
Emerging Microbes Infection, vol. 9, no. 1, (2020) pp. 386-389
Literature review as a research methodology: an overview and guidelines
Journal of Business Research, 104 (2019) PP. 333-339
How to Cite
Copyright (c) 2022 International Education and Research Journal (IERJ)
This work is licensed under a Creative Commons Attribution 4.0 International License.